Boston Scientific Q4 Profit Rises - Quick Facts

(RTTNews) - Boston Scientific Corp. (BSX) reported that its fourth-quarter net income increased to $108 million or $0.08 per share, from $60 million or $0.04 per share, last year. The company reported adjusted earnings of $290 million or $0.21 per share, for the quarter.

On average, 22 analysts polled by Thomson Reuters expected the company to report profit per share of $0.13 for the quarter. Analysts' estimates typically exclude special items. Net sales were $1.84 billion, compared to $1.82 billion, prior year. Analysts expected revenue of $1.83 billion, for the quarter. The company estimates full year 2014 revenue to be in a range of $7.30 billion to $7.50 billion. The company estimates income on a GAAP basis in a range of $0.35 to $0.40 per share, and adjusted earnings in a range of $0.75 to $0.80 per share. Analysts expect the company to report fiscal 2014 profit per share of $0.52 on revenue of $7.41 billion.

The company estimates first-quarter sales in a range of $1.755 to $1.805 billion. The company estimates earnings on a GAAP basis in a range of $0.06 to $0.08 per share. Adjusted earnings are estimated in a range of $0.16 to $0.18 per share. Analysts expect the company to report first-quarter profit per share of $0.12 on revenue of $1.80 billion.